Certificate under Regulation 74(5) of SEBI (DP) REGULATIONS, 2018 for the quarter ended 30-09-2025.
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has submitted a routine compliance certificate to BSE for the quarter ending 30 September 2025, as required under SEBI Regulation 74(5). The certificate was issued by Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent (RTA). It confirms that all share certificates received for dematerialization during the quarter were verified, accepted or rejected by the depositories within the required timeframe. It also confirms that physical certificates were mutilated and cancelled, and the depositories' names were substituted as the registered owners in the company's member register within 15 days. There are no new financial numbers, transactions, or corporate actions involved in this filing.
This is a standard procedural filing with no material impact on the stock price or shareholders. It simply reaffirms that the company's RTA is processing demat requests in compliance with SEBI rules, indicating sound back-office governance.